SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
-8.02%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$259M
AUM Growth
+$259M
(-12%)
Cap. Flow
-$5.98M
Cap. Flow
% of AUM
-2.31%
Top 10 Holdings %
Top 10 Hldgs %
96.31%
Holding
16
New
1
Increased
5
Reduced
–
Closed
2
Top Buys
| 1 |
Agilent Technologies
A
|
$26.2M |
| 2 |
Amgen
AMGN
|
$10.5M |
| 3 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$4.59M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$1.99M |
| 5 |
KIN
Kindred Biosciences, Inc.
KIN
|
$1.5M |
Top Sells
| 1 |
IDIX
IDENIX PHARMACEUTICALS INC
IDIX
|
$48.2M |
| 2 |
Labcorp
LH
|
$3.87M |
Sector Composition
| 1 | Healthcare | 84.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $69.4M | 26.8% | 12,850,000 +850,000 | +7% | +$4.59M |
|
2
Quest Diagnostics
DGX
$20.3B
| $47M | 18.16% | 775,000 | – | – |
|
|
BRLI
3
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $35.9M | 13.88% | 1,280,984 | – | – |
|
|
4
Agilent Technologies
A
$35.7B
| $26.2M | 10.12% | +460,000 | New | +$26.2M |
|
5
Merck
MRK
$210B
| $23.7M | 9.16% | 400,000 | – | – |
|
|
6
Amgen
AMGN
$155B
| $16.9M | 6.51% | 120,000 +75,000 | +167% | +$10.5M |
|
|
RPRX
7
DELISTED
Repros Therapeutics Inc.
RPRX
| $11.2M | 4.33% | 1,132,367 +129,000 | +13% | +$1.28M |
|
|
VVUS
8
DELISTED
Vivus Inc
VVUS
| $9.94M | 3.84% | 2,573,943 | – | – |
|
|
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.94M | 1.91% | 360,000 +144,798 | +67% | +$1.99M |
|
10
Enanta Pharmaceuticals
ENTA
$180M
| $4.16M | 1.6% | 105,000 | – | – |
|
|
KIN
11
DELISTED
Kindred Biosciences, Inc.
KIN
| $3.61M | 1.39% | 390,000 +161,874 | +71% | +$1.5M |
|
|
AVEO
12
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.85M | 1.1% | 2,570,759 | – | – |
|
13
Gyre Therapeutics
GYRE
$703M
| $1.59M | 0.62% | 630,000 | – | – |
|
14
Traws Pharma
TRAW
$9.89M
| $1.51M | 0.58% | 350,000 | – | – |
|
|
15
Labcorp
LH
$23.1B
| – | – | -37,824 | Closed | -$3.87M |
|
|
IDIX
16
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| – | – | -2,000,000 | Closed | -$48.2M |
|